FLUID DELIVERY APPARATUS INCLUDING A MICRONEEDLE ASSEMBLY SUITABLE FOR TREATING A MIGRAINE OR CLUSTER HEADACHE
A method for administering a medicament suitable for treating a migraine or cluster headache to a patient in need thereof includes placing a mounting surface of a fluid delivery apparatus with the medicament in contact with at least a portion of the skin of said patient. A flow rate of the medicament from the fluid delivery apparatus is adjusted such that the medicament is delivered to the patient for at least a predetermined time period. The fluid delivery apparatus includes a controller assembly having a body component defining an axis and a plunger component slidably coupled to the body component. The plunger is positionable between a first position in which the plunger is nearest to the body component and a second position in which the plunger component is furthest from the body component. A bias assembly is positioned between the body component and the plunger component. The bias assembly is configured to apply a two stage force profile to the plunger component. Also disclosed is method for administering a medicament to a patient in need thereof such that the Cmax, Tmax and AUC are within predetermined, therapeutically effective values. Such methods are effective in treating migraine and cluster headaches with sumatriptan or other medicament..
Medienart: |
Patent |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Europäisches Patentamt - (2023) vom: 01. Feb. Zur Gesamtaufnahme - year:2023 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
ROSS RUSSELL F [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Themen: |
Sonstige Themen: |
---|
Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-02-01, Last update posted on www.tib.eu: 2023-09-27, Last updated: 2023-09-29 |
---|
Patentnummer: |
EP3554618 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
EPA002239957 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | EPA002239957 | ||
003 | DE-627 | ||
005 | 20240327215147.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240327s2023 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)EPA002239957 | ||
035 | |a (EPA)EP3554618 | ||
035 | |a (EPA)62559674 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a ROSS RUSSELL F |e verfasserin |4 aut | |
245 | 1 | 0 | |a FLUID DELIVERY APPARATUS INCLUDING A MICRONEEDLE ASSEMBLY SUITABLE FOR TREATING A MIGRAINE OR CLUSTER HEADACHE |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Source: www.epo.org (no modifications made), First posted: 2023-02-01, Last update posted on www.tib.eu: 2023-09-27, Last updated: 2023-09-29 | ||
520 | |a A method for administering a medicament suitable for treating a migraine or cluster headache to a patient in need thereof includes placing a mounting surface of a fluid delivery apparatus with the medicament in contact with at least a portion of the skin of said patient. A flow rate of the medicament from the fluid delivery apparatus is adjusted such that the medicament is delivered to the patient for at least a predetermined time period. The fluid delivery apparatus includes a controller assembly having a body component defining an axis and a plunger component slidably coupled to the body component. The plunger is positionable between a first position in which the plunger is nearest to the body component and a second position in which the plunger component is furthest from the body component. A bias assembly is positioned between the body component and the plunger component. The bias assembly is configured to apply a two stage force profile to the plunger component. Also disclosed is method for administering a medicament to a patient in need thereof such that the Cmax, Tmax and AUC are within predetermined, therapeutically effective values. Such methods are effective in treating migraine and cluster headaches with sumatriptan or other medicament. | ||
650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
650 | 4 | |a che | |
650 | 4 | |a med | |
650 | 4 | |a A61M: Devices for introducing media into, or onto, the body (introducing media into or onto the bodies of animals a61d0007000000; means for inserting tampons a61f0013260000; devices for administering food or medicines orally a61j; containers for collecting, storing or administering blood or medical fluids a61j0001050000); devices for transducing body media or for taking media from the body (surgery a61b; chemical aspects of surgical articles a61l; magnetotherapy using magnetic elements placed within the body a61n0002100000); devices for producing or ending sleep or stupor | |
650 | 4 | |a 615 | |
700 | 0 | |a BAKER ANDREW T |4 aut | |
700 | 0 | |a HAGAN LUKE |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 01. Feb. |
773 | 1 | 8 | |g year:2023 |g day:01 |g month:02 |
856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/62559674/publication/EP3554618A1?q=EP3554618 |z kostenfrei |3 Volltext |
912 | |a GBV_EPA | ||
951 | |a AR | ||
952 | |j 2023 |b 01 |c 02 |